Search Results 321-330 of 16642 for ������������KA���:ZA31���24������ ���������������������������������

  1. Herniated disk - Doctors and departments - Mayo Clinic

    Doctors who treat this condition · Narrow your search · Displaying 41-24 out of 24 doctors available.

  2. Publications - Zech G. Franks, M.D. - Mayo Clinic

    2013 Nov 07; 93(5):812-24. Epub 2013 Oct 17. View PubMed; Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, Zimmerman GA, Weyrich ...

  3. Whipple procedure - Doctors & Departments - Mayo Clinic

    Accessed March 24, 2023. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.

  4. Publications - Tahir S. Kafil, M.D. - Mayo Clinic

    ... KA, International Network of Special Immunization Services (INSIS) Members. ... 2022 Feb; 4 (2):237-239 Epub 2021 Sept 24. View PubMed; Kafil TS, Sparrow R ...

  5. Drugs and Supplements that Start with D - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...

  6. Neurology - Referrals - Mayo Clinic

    Jacksonville, Florida. Call 800-634-1417 (toll-free) or 904-953-0321, 24 hours a day, seven days a week.

  7. Publications - Vanessa V. Marin Collazo, M.D. - Mayo Clinic

    ... KA, Staff NP, Gorcenco S, Puschmann A, Lemos J, Januario C, LeDoux MS, Friedman JH, Polke J, Labrum R, Shakkottai V, McLoughlin HS, Paulson HL, Konno T ...

  8. Publications - Rohit D. Divekar - Mayo Clinic

    Bhavnani SK, Dang B, Penton R, Visweswaran S, Bassler KE, Chen T, Raji M ... 2015 Oct; 70 (10):1230-8 Epub 2015 June 24. View PubMed; Pyle RC, Divekar R ...

  9. To Assess the Effectiveness, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed by a 52-week ...

  10. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

    Participants will be randomized to receive either MMB or ruxolitinib for 24 weeks during a double-blind treatment phase, after which they will be eligible to ...